Goldman Sachs Maintains Neutral on RXO, Lowers Price Target to $21

RXO, Inc. Common Stock

RXO, Inc. Common Stock

RXO

0.00

Goldman Sachs analyst Jordan Alliger maintains RXO (NYSE: RXO) with a Neutral and lowers the price target from $24 to $21.